NSCLC | Non-small-cell lung cancer |
EGFR | Epidermal growth factor receptor |
TKI | Tryrosine kinase inhibitor |
miRNA | microRNA |
miR-506-3p | microRNA-506-3p |
ER | Erlotinib resistance |
SHH | Sonic Hedgehog |
EMT | Epithelial–mesenchymal transition |
rhSHH Pr. | Recombinant SHH protein |
NGS | Next-generation sequencing |
PFS | Progression-free survival |
OS | Overall survival |